Loading
Latest filing published 08 Apr 2022 for Cell MedX Corp., €1,376.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Bradley S. Hargreaves is a declared insider of Stimcell Energetics Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 13 August 2020 to 6 April 2022, the count stands at 39 filings.
No open-market purchase appears, only 37 sales worth €170k. Besides market trades, the filings include 1 option exercise. So far in 2022, the count stands at no purchases and 6 sales.
On 8 April 2022 came the latest disclosure, an open-market sale for €1,376 in Stimcell Energetics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations